- Investing Ideas
- /
- Swedish Biotech Stocks
Swedish Biotech Stocks
Results
53
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
53 companies
Swedish Orphan Biovitrum
Market Cap: SEK 106.6b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 310.40
7D
3.0%
1Y
11.5%
Camurus
Market Cap: SEK 31.3b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 534.00
7D
-14.6%
1Y
-3.8%
Vitrolife
Market Cap: SEK 21.1b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 156.10
7D
-1.8%
1Y
-15.9%
Bonesupport Holding
Market Cap: SEK 18.5b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 280.60
7D
-0.4%
1Y
11.8%
BioArctic
Market Cap: SEK 16.4b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 185.00
7D
7.6%
1Y
-17.0%
Biotage
Market Cap: SEK 11.4b
Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.
BIOT
SEK 141.80
7D
0.2%
1Y
-19.3%
BioGaia
Market Cap: SEK 10.7b
A healthcare company, provides probiotic products worldwide.
BIOG B
SEK 105.70
7D
-0.5%
1Y
-21.5%
MedCap
Market Cap: SEK 6.8b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.
MCAP
SEK 449.50
7D
1.5%
1Y
-13.1%
Swedencare
Market Cap: SEK 6.7b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 42.10
7D
4.2%
1Y
-24.4%
Flerie
Market Cap: SEK 3.5b
A venture capital firm specializing in early-stage investments.
FLERIE
SEK 44.90
7D
1.6%
1Y
n/a
BICO Group
Market Cap: SEK 2.5b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 35.52
7D
1.1%
1Y
-20.2%
Vicore Pharma Holding
Market Cap: SEK 1.9b
A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
VICO
SEK 8.19
7D
1.5%
1Y
-56.8%
Devyser Diagnostics
Market Cap: SEK 1.8b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 107.60
7D
-3.2%
1Y
7.6%
Saniona
Market Cap: SEK 1.1b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 8.39
7D
5.9%
1Y
318.5%
Xspray Pharma
Market Cap: SEK 1.1b
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 30.30
7D
-7.1%
1Y
-47.8%
FluoGuide
Market Cap: SEK 559.8m
A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.
FLUO
SEK 41.10
7D
4.3%
1Y
-16.0%
Cinclus Pharma Holding
Market Cap: SEK 491.4m
A clinical stage pharmaceutical company, engages in the development of the drug candidate for the treatment of related diseases.
CINPHA
SEK 10.56
7D
7.8%
1Y
n/a
Orexo
Market Cap: SEK 484.5m
A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.
ORX
SEK 14.04
7D
-2.6%
1Y
-34.8%
Ascelia Pharma
Market Cap: SEK 479.8m
A biotech company, focuses on orphan oncology treatments in Sweden.
ACE
SEK 4.14
7D
6.4%
1Y
-58.6%
Xbrane Biopharma
Market Cap: SEK 404.5m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.26
7D
-1.1%
1Y
24.5%
Moberg Pharma
Market Cap: SEK 384.5m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 8.24
7D
9.1%
1Y
-70.6%
IRLAB Therapeutics
Market Cap: SEK 374.0m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.
IRLAB A
SEK 7.21
7D
-4.6%
1Y
-53.6%
Karolinska Development
Market Cap: SEK 266.3m
A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.
KDEV
SEK 0.99
7D
-1.2%
1Y
-36.8%
Mendus
Market Cap: SEK 261.9m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 5.20
7D
4.9%
1Y
-45.3%
Corline Biomedical
Market Cap: SEK 244.4m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.
CLBIO
SEK 9.98
7D
-4.0%
1Y
-1.2%
Medivir
Market Cap: SEK 198.8m
A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally.
MVIR
SEK 1.77
7D
-2.1%
1Y
-39.5%
Enorama Pharma
Market Cap: SEK 168.1m
A pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden.
ERMA
SEK 2.78
7D
6.5%
1Y
3.3%
SenzaGen
Market Cap: SEK 155.8m
Provides non-animal tests for assessing a substance’s allergenicity.
SENZA
SEK 5.28
7D
-7.4%
1Y
-43.1%
Toleranzia
Market Cap: SEK 129.5m
A biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases.
TOL
SEK 0.48
7D
6.9%
1Y
-21.6%
AroCell
Market Cap: SEK 129.0m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
AROC
SEK 0.56
7D
-5.4%
1Y
40.0%
Vivesto
Market Cap: SEK 124.3m
Develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden.
VIVE
SEK 0.23
7D
1.3%
1Y
-22.6%
Kancera
Market Cap: SEK 123.1m
Develops drugs for inflammatory diseases and cancer in Sweden and internationally.
KAN
SEK 1.02
7D
-3.4%
1Y
-39.9%
Abera Bioscience
Market Cap: SEK 110.5m
A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.
ABERA
SEK 7.20
7D
-1.4%
1Y
33.3%
Nanologica
Market Cap: SEK 107.8m
A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.
NICA
SEK 1.22
7D
-1.2%
1Y
-79.5%
Biovica International
Market Cap: SEK 94.7m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.
BIOVIC B
SEK 0.97
7D
26.0%
1Y
-43.7%
PEPTONIC medical
Market Cap: SEK 92.1m
A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.
PMED
SEK 0.06
7D
0%
1Y
-27.7%